Atlas Trials

Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Conditions

Clinical trial NCT04882826 · UNKNOWN

Trial details

NCT number
NCT04882826
Sponsor
Pharmtechnology LLC
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2021-05-10
Primary completion
2021-05-30
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.